All In MedTech

FDA Clearance Tracker · DEN140016

STUDIO ON THE CLOUD DATA MANAGEMENT SOFTWARE

A De Novo grant creates a new device type for a low to moderate risk device with nothing on the market to compare it to. Later devices of this type can use it as their comparison in a 510(k).

Last checked: Nov 20, 2026Latest source record: Aug 19, 2014 (this decision)Source: openFDAMethods & limitations

De NovoNew device type

Decided

Aug 19, 2014

De Novo granted

Time to decision

119 days

Received Apr 22, 2014. Calendar days, including time FDA spent waiting on the applicant.

Pathway

De Novo

Direct

Device class

Class I

The decision

FDA number
DEN140016
Device name
STUDIO ON THE CLOUD DATA MANAGEMENT SOFTWARE
Applicant
Dexcom, Inc.
Applicant location
San Diego, CA
Received
Apr 22, 2014
Decided
Aug 19, 2014
Decision
De Novo granted
Submission type
Direct

Device type

Device class
Class I
Regulation
21 CFR 862.2120

Every decision under product code PHV

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Dexcom, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.